Seeing Is Believing
Currently out of the existing stock ratings of Do Kim, 226 are a BUY (82.48%), 48 are a HOLD (17.52%).
Analyst Do Kim, currently employed carries an average stock price target met ratio of 51.31% that have a potential upside of 38.31% achieved within 244 days. Previously, Do Kim worked at PIPER SANDLER.
Do Kim’s has documented 544 price targets and ratings displayed on 27 stocks. The coverage was on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 22-Feb-2024.
Analyst best performing recommendations are on AKCA (AKCEA THERAPEUTICS).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 11/7/2016. The price target of $48 was fulfilled within 8 days with a profit of $15.88 (49.44%) receiving and performance score of 61.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
2 months 16 days ago
(20-Aug-2024)
0/2 (0%)
$6.55 (120.18%)
Buy
$5
$2.27 (83.15%)
$7
3 months 25 days ago
(11-Jul-2024)
0/4 (0%)
$1.87 (59.74%)
Buy
$22
$19.27 (705.86%)
$32
1 years 2 days ago
(03-Nov-2023)
0/3 (0%)
$17.3 (368.09%)
Buy
$24
$21.27 (779.12%)
$30
1 years 3 months 1 days ago
(04-Aug-2023)
0/2 (0%)
$17.96 (297.35%)
Buy
$28
$25.27 (925.64%)
$34
1 years 6 months ago
(05-May-2023)
1/6 (16.67%)
$22.01 (367.45%)
24
What Year was the first public recommendation made by Do Kim?